The Comprehensive cancer management as an effort to improve the quality of cancer care in Indonesia towards a Golden Indonesia 2045

Abstract

Cancer remains a major public health challenge in Indonesia, with increasing incidence and mortality rates. GLOBOCAN 2020 data highlights a growing cancer burden, particularly in developing countries, where late-stage diagnoses and treatment delays contribute to poor outcomes. Breast cancer is the most prevalent cancer in Indonesia, followed by cervical cancer, leukemia, and colorectal cancer. Despite national efforts, a high proportion of patients present at advanced stages, leading to decreased survival rates and increased healthcare costs. This study examines the factors influencing cancer diagnosis and treatment delays in Indonesia. A comprehensive literature review was conducted, analyzing hospital-based cancer registry data, epidemiological trends, and healthcare system challenges. Key barriers include limited screening coverage, inadequate public awareness, reliance on alternative therapies, and systemic delays in referrals, diagnostics, and treatment initiation. Additionally, disparities in access to advanced cancer care exacerbate the issue. Findings emphasize the need for a comprehensive cancer management approach, integrating early detection programs, precision medicine, and multidisciplinary care. Strengthening primary healthcare services, enhancing oncology education for healthcare professionals, and developing comprehensive cancer centers are crucial steps. National cancer control policies must align with global strategies to improve patient outcomes. As Indonesia approaches its “Golden Indonesia 2045” vision, it is essential to prioritize cancer prevention and treatment. Addressing healthcare system inefficiencies, fostering collaborations between government, academia, and private sectors, and ensuring equitable access to quality cancer care will be pivotal in reducing the cancer burden and improving survival rates.